FDA's Center for Drug Evaluation and Research reached one dozen novel agent approvals this year after a shower of approvals in the last week – Intercept Pharmaceuticals Inc.'s Ocaliva, Biogen Inc. and AbbVie Inc.'s Zinbryta and two PET imaging agents.
Keeping Track: FDA Approval Activity Heats Up With Ocaliva, Zinbryta And More
The latest drug development news and highlights from our FDA Performance Tracker.